Pathogenicity and Virulence of Clostridium Perfringens

Pathogenicity and Virulence of Clostridium Perfringens

UC Davis UC Davis Previously Published Works Title Pathogenicity and virulence of Clostridium perfringens. Permalink https://escholarship.org/uc/item/18h6c9w7 Journal Virulence, 12(1) ISSN 2150-5594 Authors Mehdizadeh Gohari, Iman A Navarro, Mauricio Li, Jihong et al. Publication Date 2021-12-01 DOI 10.1080/21505594.2021.1886777 Peer reviewed eScholarship.org Powered by the California Digital Library University of California VIRULENCE 2021, VOL. 12, NO. 1, 723–753 https://doi.org/10.1080/21505594.2021.1886777 REVIEW ARTICLE Pathogenicity and virulence of Clostridium perfringens Iman Mehdizadeh Goharia#, Mauricio A. Navarrob#, Jihong Lia, Archana Shresthaa, Francisco Uzalb, and Bruce A. McClanea aDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; bCalifornia Animal Health and Food Safety Laboratory, School of Veterinary Medicine, University of California Davis, San Bernardino, CA, USA ABSTRACT ARTICLE HISTORY Clostridium perfringens is an extremely versatile pathogen of humans and livestock, causing wound Received 01 September 2020 infections like gas gangrene (clostridial myonecrosis), enteritis/enterocolitis (including one of the most Revised 25 January 2021 common human food-borne illnesses), and enterotoxemia (where toxins produced in the intestine are Accepted 29 January 2021 absorbed and damage distant organs such as the brain). The virulence of this Gram-positive, spore- KEYWORDS forming, anaerobe is largely attributable to its copious toxin production; the diverse actions and roles in Clostridium perfringens; infection of these toxins are now becoming established. Most C. perfringens toxin genes are encoded on toxins; sporulation; quorum conjugative plasmids, including the pCW3-like and the recently discovered pCP13-like plasmid families. sensing; two-component Production of C. perfringens toxins is highly regulated via processes involving two-component regulatory regulatory systems; gas systems, quorum sensing and/or sporulation-related alternative sigma factors. Non-toxin factors, such as gangrene; enteritis/ degradative enzymes like sialidases, are also now being implicated in the pathogenicity of this bacterium. enterocolitis; enterotoxemia These factors can promote toxin action in vitro and, perhaps in vivo, and also enhance C. perfringens intestinal colonization, e.g. NanI sialidase increases C. perfringens adherence to intestinal tissue and generates nutrients for its growth, at least in vitro. The possible virulence contributions of many other factors, such as adhesins, the capsule and biofilms, largely await future study. Introduction (A-G). The importance of toxins for C. perfringens patho­ genicity is apparent from the association of specific toxin The Gram-positive, spore-forming bacterium Clostridium types with different disease niches (Table 3, with discussion perfringens is considered to be anaerobic since it cannot later). For example, type A strains lacking any toxin- grow in the presence of air [1]. However, compared to most encoding plasmids cause gas gangrene (myonecrosis) and other anaerobes, this bacterium is relatively resistant to other histotoxic infections. However, those strains are not killing by oxygen [1]. C. perfringens is also an unusual a major cause of GI disease and, in fact, are commonly anaerobe by possessing an extremely rapid doubling time; present in the normal GI microbiota of humans and other its short generation time of <10 min [1] contributes to animals. Except for type F strains carrying a chromosomal virulence by allowing this bacterium to quickly reach enterotoxin gene (cpe), C. perfringens strains usually need to pathogenic burdens in foods, in wounds, or in the intestine. acquire a plasmid-borne toxin gene in order to cause GI C. perfringens lacks flagella but exhibits gliding motility disease, as discussed later. mediated by type IV pili, which also contribute to other This review will briefly update current knowledge of potentially virulence-related functions like biofilm forma­ C. perfringens pathogenicity, including the structure, action, tion and adherence [2]. and genetics of its toxins, which have been the traditional Although it has a ubiquitous environmental presence in focus of C. perfringens research. Additionally, studies are decaying vegetation, soil, feces, and the normal gastroin­ now exploring the contributions of cell/tissue adherence, testinal (GI) tract microbiota of humans and other animals, degradative enzymes, and sporulation to C. perfringens C. perfringens is also a major pathogen of humans and virulence, so those emerging topics will also be discussed. livestock. The virulence of this bacterium can be ascribed, in large part, to its armory of ~20 potent toxins (Table 1 and Figure 1). Toxin production patterns vary considerably Proven or potential virulence factors among different strains, providing the basis for a recently This section will briefly introduce the proven or potential revised [3] classification scheme (Table 2) that assigns virulence factors of C. perfringens. The role of proven, or C. perfringens isolates to one of the seven toxin types CONTACT Bruce A. Mcclane [email protected] #Co-equal contribution © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 724 I. MEHDIZADEH GOHARI ET AL. Table 1. Characteristics of toxins and extracellular degradative enzymes produced by C. perfringens. Molecular Pore size Number of monomers Toxin/Enzyme Biological activitya Cellular targeta size (kDa)a (nm)b forming the poreb Gene locationc CPA Phospholipase C and Plasma membrane 42.5 - - Chromosome Sphingomyelinase CPB Pore-forming toxin Plasma membrane 35 1.2 7? pCW3-like plasmid ETX Pore-forming toxin Plasma membrane 33 1 7 pCW3-like plasmid ITX Actin-specific ADP- Cytoskeleton Iota-a: 47.5 ~1 7 pCW3-like plasmid ribosyltransferase Iota-b: 71.5 CPE Pore-forming toxin Plasma membrane 35 1.4 6 Chromosome or pCW3-like plasmid NetB Pore-forming toxin Plasma membrane 33 1.8 7 pCW3-like plasmid NetF Pore-forming toxin Plasma membrane 31.7 4-6 6-9 pCW3-like plasmid NetE Putative pore-forming toxin Plasma membrane 32.9 ND ND pCW3-like plasmid NetG Putative pore-forming toxin Plasma membrane 31.7 ND ND pCW3-like plasmid BEC Actin-specific ADP- Cytoskeleton BEC-a: 47 - - pCP13-like plasmid ribosyltransferase BEC-b: 83 TpeL Ras-specific mono- Rho-signal transduction ~206 - - Plasmid glucosyltransferase CPB2 Putative pore-forming toxin Plasma membrane 28 ND ND pCW3-like or pCP13- like plasmid PFO Pore-forming toxin; cholesterol- Plasma membrane 54 25-45 40-50 Chromosome dependent cytolysin Delta toxin Pore-forming toxin Plasma membrane 32 4-5 7? Plasmid NanI Sialidase Mucus/Surface 77 - - Chromosome glycolipids NanJ Sialidase Mucus/Surface 129 - - Chromosome glycolipids/ glycoproteins NanH Sialidase Mucus-Surface 43 - - Chromosome glycolipids/ glycoproteins Kappa toxin Collagenase Surface glycolipids/ ~ 80 - - Chromosome glycoproteins Mu toxin Hyaluronidase Hyaluronic acid 182.6 - - Chromosome Lambda toxin Protease ? 36 - - pCW3-like plasmid α-clostripain Cysteine Protease ? 59.6 - - Chromosome aCompiled from [6,8,22,37,45,59,64,68,72,82,255,293–296] bCompiled from [5,28,31,36,58,60,68,73,78,297–301] cCompiled from [12,62,109,112,115,120,123,136–144,302,303] strongly suggested, virulence factors in disease will then be phospholipase and sphingomyelinase activities [4]. In discussed later in the molecular pathogenesis section. addition to these enzymatic events in the plasma mem­ Major Toxins Used for C. perfringens Isolate Typing brane, binding to GM1 allows CPA to interact with the Alpha toxin (CPA). Virtually all C. perfringens iso­ tropomyosin receptor kinase A (TrkA), leading to acti­ lates produce CPA, a zinc-containing phospholipase vation of the MEK/ERK pathway [4]. Different intricate C enzyme of 370 amino acids that consists of molecular pathways and cellular responses associated a membrane-binding C-domain composed of a β- with CPA have been extensively reviewed, including sheet, a catalytic N-domain composed of α-helices, cell death and the production of reactive oxygen species and a central loop domain containing a ganglioside (ROS) or IL-8 [6]. GM1a binding site [4]. Based on their amino acid Beta toxin (CPB). C. perfringens type B and C isolates sequences and/or antigenic cross-reactivity, CPA is produce CPB as a pro-toxin of 336 amino acids, contain­ related to the phospholipases of Clostridium bifermen­ ing a 27-amino acid signal sequence that is cleaved during tans, Clostridium novyi, Clostridium absonum and secretion. This results in a mature toxin of ~35 kDa [7]. Clostridium barati [5]. CPB is a β-pore-forming toxin (PFT) of the α-hemolysin CPA is thought to use ganglioside GM1 as a receptor family and shares amino acid sequence similarity with the [4]. Through the hydrolysis of phosphatidylcholine and β-PFTs of Staphylococcus aureus [8]. sphingomyelin in the plasma membrane, CPA induces There is some controversy regarding CPB receptors. the formation of diacylglycerol (DAG) and ceramide An early study reported that the P2X7 receptor is the (CER), respectively [4]. Furthermore, through interac­ CPB receptor for cultured THP-1 monocyte cells [9]. tions with Gi type GTP-binding

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    32 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us